Australian Regenerative Medicine Institute

From Wikipedia, the free encyclopedia
Jump to: navigation, search

The Australian Regenerative Medicine Institute (ARMI) is a $153 million medical research centre that opened in April 2009.[1] It is based at the Clayton campus of Monash University, in the Monash Science Technology Research and Innovation Precinct, along with EMBL Australia. Its foundation director was Professor Nadia Rosenthal.[2][3] Rosenthal has previously served at the European Molecular Biology Laboratory and Harvard Medical School. Professor Peter Currie was appointed Director in February 2016, following Rosenthal's departure back to the US.

ARMI is one of the world's largest regenerative medicine and stem cell research hubs.[4] Its research aims to restore and regenerate damaged tissue and organs by injecting or implanting cells to allow the human body to heal and recover.[5] Research focuses on developing effective treatments for a range of currently incurable diseases, such as cancer, arthritis and other musculoskeletal conditions, diabetes and cardiovascular diseases, as well as neurotrauma. In addition, ARMI is also looking at technologies to treat ageing itself via regeneration.

Facilities at the Institute include FishCore, the largest zebrafish facility of its kind in the Southern Hemisphere.[6]

History of ARMI[edit]

The Australian Regenerative Medicine Institute officially opened on April 2009.[7]

The institute was established through a joint venture between Monash University and the Victorian Government to deliver the next generation of discoveries in regenerative medicine.

External links[edit]


Coordinates: 37°54′38″S 145°7′45″E / 37.91056°S 145.12917°E / -37.91056; 145.12917